Cost-effectiveness of Multigene Testing for All Patients With Breast Cancer

This cost-effectiveness microsimulation modeling study estimates incremental lifetime effects, costs, and cost-effectiveness of multigene testing of all patients with breast cancer compared with selective testing based on family history or clinical criteria.

Read the full article here

Related Articles